Companies: 10,795·Total market cap: $144.5T
Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc.

RANINASDAQHealthcare● Active
$0.84
+$0.01(+1.22%)
Market Cap$54842672
P/E Ratio
52W High$3.87
52W Low$0.387

Rani Therapeutics Holdings, Inc.(RANI)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RANI · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.63M$1.03M$0.00M$0.00M$2.72M
Cost of Revenue$0.90M$0.00M$0.82M$0.00M$0.00M
Gross Profit$0.73M$1.03M($0.82M)$0.00M$2.72M
Gross Margin %(computed)44.89%100.00%100.00%
Operating Expenses
R&D Expenses$20.20M$26.68M$39.62M$36.61M$26.48M
G&A Expenses$19.74M$23.95M$26.48M$26.84M$27.83M
Total Operating Expenses$39.04M$54.34M$65.28M$63.45M$54.32M
Operating Income($38.31M)($53.31M)($66.10M)($63.45M)($51.60M)
Operating Margin %(computed)
Interest Income$0.83M$1.76M$3.30M$1.25M$0.09M
Interest Expense$2.89M$5.03M$5.08M$1.07M$0.47M
Income Before Tax($40.95M)($30.02M)($67.88M)($63.27M)($53.05M)
Income Tax Expense$0.00M$26.57M$0.00M$0.07M$0.04M
Net Income($29.67M)($30.02M)($33.97M)($30.59M)($8.33M)
Net Margin %(computed)-306.62%
Per Share & EBITDA
EPS (Basic)$-0.45$-1.05$-1.33$-1.28$-0.42
Wtd Avg Shares66.14M28.48M25.50M23.82M19.53M
EBITDA($37.41M)($50.52M)($65.28M)($61.66M)($52.08M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Rani Therapeutics Holdings, Inc.

关于Rani Therapeutics Holdings, Inc.(RANI)损益表

Rani Therapeutics Holdings, Inc.(RANI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RANI实现营收$0.00B,毛利润$0.00B(毛利率44.89%),净利润($0.03B)(净利率-1817.09%)。

常见问题

RANI · 4 问

Rani Therapeutics Holdings, Inc.(RANI)2025财年营收为$0.00B,同比up58.9%。

RANI revenueRANI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09